Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis.

Thomadakis C, Gountas I, Duffell E, Gountas K, Bluemel B, Seyler T, Pericoli FM, Kászoni-Rückerl I, El-Khatib Z, Busch M, Schmutterer I, Vanwolleghem T, Klamer S, Plettinckx E, Mortgat L, Van Beckhoven D, Varleva T, Kosanovic Licina ML, Nemeth Blazic T, Nonković D, Theophanous F, Nemecek V, Maly M, Christensen PB, Cowan S, Rüütel K, Brummer-Korvenkontio H, Brouard C, Steffen G, Krings A, Dudareva S, Zimmermann R, Nikolopoulou G, Molnár Z, Kozma E, Gottfredsson M, Murphy N, Kondili LA, Tosti ME, Ciccaglione AR, Suligoi B, Nikiforova R, Putnina R, Jancoriene L, Seguin-Devaux C, Melillo T, Boyd A, van der Valk M, Op de Coul E, Whittaker R, Kløvstad H, Stępień M, Rosińska M, Valente C, Marinho RT, Popovici O, Avdičová M, Kerlik J, Klavs I, Maticic M, Diaz A, Del Amo J, Lundberg Ederth J, Axelsson M, Nikolopoulos G

Open source

DOI
10.1016/j.lanepe.2023.100792
Published
2024 Jan
Container
The Lancet regional health. Europe
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lanepe.2023.100792,
  title = {Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis.},
  author = {Thomadakis C and Gountas I and Duffell E and Gountas K and Bluemel B and Seyler T and Pericoli FM and Kászoni-Rückerl I and El-Khatib Z and Busch M and Schmutterer I and Vanwolleghem T and Klamer S and Plettinckx E and Mortgat L and Van Beckhoven D and Varleva T and Kosanovic Licina ML and Nemeth Blazic T and Nonković D and Theophanous F and Nemecek V and Maly M and Christensen PB and Cowan S and Rüütel K and Brummer-Korvenkontio H and Brouard C and Steffen G and Krings A and Dudareva S and Zimmermann R and Nikolopoulou G and Molnár Z and Kozma E and Gottfredsson M and Murphy N and Kondili LA and Tosti ME and Ciccaglione AR and Suligoi B and Nikiforova R and Putnina R and Jancoriene L and Seguin-Devaux C and Melillo T and Boyd A and van der Valk M and Op de Coul E and Whittaker R and Kløvstad H and Stępień M and Rosińska M and Valente C and Marinho RT and Popovici O and Avdičová M and Kerlik J and Klavs I and Maticic M and Diaz A and Del Amo J and Lundberg Ederth J and Axelsson M and Nikolopoulos G},
  year = {2024},
  journal = {The Lancet regional health. Europe},
  doi = {10.1016/j.lanepe.2023.100792},
  url = {https://doi.org/10.1016/j.lanepe.2023.100792}
}

RIS

TY  - JOUR
TI  - Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis.
AU  - Thomadakis C
AU  - Gountas I
AU  - Duffell E
AU  - Gountas K
AU  - Bluemel B
AU  - Seyler T
AU  - Pericoli FM
AU  - Kászoni-Rückerl I
AU  - El-Khatib Z
AU  - Busch M
AU  - Schmutterer I
AU  - Vanwolleghem T
AU  - Klamer S
AU  - Plettinckx E
AU  - Mortgat L
AU  - Van Beckhoven D
AU  - Varleva T
AU  - Kosanovic Licina ML
AU  - Nemeth Blazic T
AU  - Nonković D
AU  - Theophanous F
AU  - Nemecek V
AU  - Maly M
AU  - Christensen PB
AU  - Cowan S
AU  - Rüütel K
AU  - Brummer-Korvenkontio H
AU  - Brouard C
AU  - Steffen G
AU  - Krings A
AU  - Dudareva S
AU  - Zimmermann R
AU  - Nikolopoulou G
AU  - Molnár Z
AU  - Kozma E
AU  - Gottfredsson M
AU  - Murphy N
AU  - Kondili LA
AU  - Tosti ME
AU  - Ciccaglione AR
AU  - Suligoi B
AU  - Nikiforova R
AU  - Putnina R
AU  - Jancoriene L
AU  - Seguin-Devaux C
AU  - Melillo T
AU  - Boyd A
AU  - van der Valk M
AU  - Op de Coul E
AU  - Whittaker R
AU  - Kløvstad H
AU  - Stępień M
AU  - Rosińska M
AU  - Valente C
AU  - Marinho RT
AU  - Popovici O
AU  - Avdičová M
AU  - Kerlik J
AU  - Klavs I
AU  - Maticic M
AU  - Diaz A
AU  - Del Amo J
AU  - Lundberg Ederth J
AU  - Axelsson M
AU  - Nikolopoulos G
PY  - 2024
JO  - The Lancet regional health. Europe
DO  - 10.1016/j.lanepe.2023.100792
UR  - https://doi.org/10.1016/j.lanepe.2023.100792
ER  -

APA

C, T., I, G., E, D., K, G., B, B., T, S., FM, P., I, K., Z, E., M, B., I, S., T, V., S, K., E, P., L, M., D, V. B., T, V., ML, K. L., T, N. B., D, N., F, T., V, N., M, M., PB, C., S, C., K, R., H, B., C, B., G, S., A, K., S, D., R, Z., G, N., Z, M., E, K., M, G., N, M., LA, K., ME, T., AR, C., B, S., R, N., R, P., L, J., C, S., T, M., A, B., M, V. D. V., E, O. D. C., R, W., H, K., M, S., M, R., C, V., RT, M., O, P., M, A., J, K., I, K., M, M., A, D., J, D. A., J, L. E., M, A., & G, N. (2024). Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis.. The Lancet regional health. Europe. https://doi.org/10.1016/j.lanepe.2023.100792

Source records